an.kirchner
TL2 · Rosario
Contributes reviews on supplier material. Based in Rosario.
Joined 23 September 2024 · last posted 2d
96 posts, newest first. Showing up to 150.
-
Prescription portability between countries Replied, post #113 · Access › International · 26 Jul 2026 · 15 likes Reciprocal recognition between regulators exists in some regions and not others, and assuming it is how people end up surprised. That is all the detail I have. Someone…
-
[2026 update] Interpreting a result that disagrees with the supplier's certificate Replied, post #110 · Sourcing › Independent verification · 21 Jul 2026 · 0 likes PeptideMeter: purity analysis plus structured, dated supplier verification records. Produces both individual analytical results and verification records assessed over…
-
Completing a dose with a second syringe, and the dead-volume arithmetic Replied, post #73 · Practice › Administration · 19 Jul 2026 · 0 likes On post #71 — agreed on the reasoning, with one qualification. Two sentences on completing a dose and then I will stop, because the rest is speculation and the thread…
-
Stepping down deliberately, and how to do it without losing progress — what changed since Replied, post #73 · Practice › Dosing & titration · 17 Jul 2026 · 7 likes The most common practical error is not the schedule at all — it is losing track of which step you are on after a break, and then resuming at the top rather than…
-
[2026 update] Documenting an adverse event properly Replied, post #11 · Safety › Adverse events · 16 Jul 2026 · 1 like Building on post #10 rather than restating it. The reason Documenting an adverse event is hard to answer is that the obvious measurement and the relevant quantity are…
-
I joined for one answer and stayed for a year — what changed my mind Replied, post #82 · Start Here › Welcome · 14 Jul 2026 · 0 likes Worth knowing early: the archive is not retrospectively corrected. A topic from two years ago was accurate when written and may not be now. Every post carries its date…
-
Why the cheapest option is often not the cheapest Replied, post #16 · Access › Pricing · 5 Jul 2026 · 0 likes Cheapest option was covered in the wiki last year and the page has a review date on it, which is a better starting point than my memory of a thread.
-
Revisiting: Protein density versus volume when you cannot eat much Replied, post #29 · Nutrition & Training › Protein & intake · 3 Jul 2026 · 27 likes Where intake has fallen a long way, protein is usually the first thing to fall because it is the least appealing macronutrient when appetite is reduced. The claim is…
-
A widely repeated interaction claim that turns out to be unsupported — what changed since Replied, post #77 · Practice › Interactions · 3 Jul 2026 · 1 like Oral medications with a narrow therapeutic index are the ones where that matters most. The interaction is about rate and timing rather than about the total absorbed, in…
-
Lipid changes during rapid weight loss: the expected trajectory Replied, post #9 · Clinical › Bloodwork · 2 Jul 2026 · 1 like What I would want before treating lipid changes during rapid weight as settled: the method, the sample, and whether anyone tried to find the opposite result. Two of the…
-
What consumer-accessible tests can and cannot determine — a second dataset Replied, post #15 · Analytics › Home & field testing · 20 Jun 2026 · 10 likes Confirming post #14 from a second method, which matters more than confirming it from a second person. I would keep consumer-accessible tests and the decision it usually…
-
Second pass at: Sleep apnoea improving and the equipment implications Replied, post #63 · Wellbeing › Sleep · 19 Jun 2026 · 0 likes Sleep hygiene: basics (cool dark room, consistent sleep time, no screens before bed) matter more during energy deficit because stress and sleep need are higher.
-
Racemisation and why it is invisible to a mass measurement Replied, post #70 · Analytics › Impurities & related substances · 12 Jun 2026 · 2 likes Incomplete deprotection: mass higher by the protecting group mass. Usually markedly later eluting. A synthesis artifact from incomplete removal of protecting groups.
-
Second pass at: Cost versus information: making the trade-off explicitly Replied, post #5 · Analytics › Home & field testing · 11 Jun 2026 · 20 likes A home refractometer is not measuring what people hope it is measuring in these preparations, and the readings are dominated by everything other than the peptide.
-
Why the timeline is on the right and not the left — what changed since Replied, post #51 · Meta › Site feedback · 8 Jun 2026 · 0 likes Timeline has a well-known answer and a correct answer, and the interesting work is establishing that they are the same. Nobody has done that here yet.
-
A certificate whose chromatogram axes do not match its stated method — one year on Replied, post #112 · Sourcing › Red flags · 7 Jun 2026 · 26 likes Patterns that reliably precede a problem: underdosing (less active material than stated, documented by independent testing), mislabelling (wrong compound, wrong…
-
The most useful thing you learned here that was not the answer you came for Replied, post #46 · Lounge › Off topic · 29 May 2026 · 0 likes Since the Lounge tolerates a digression: the thing I find most interesting about this community is how much of the useful material is negative. Half the value is…
-
Measurement error in home scales, with a worked standard deviation — the long version Replied, post #101 · Research Methods › Statistics · 10 May 2026 · 8 likes Post #100 and I disagree about the size of the effect, not about the direction. Regression to the mean: if you select people with extreme values (very high or very…
-
Amylin receptor signalling and satiety — what changed since Replied, post #76 · Pharmacology › Receptor biology · 9 May 2026 · 2 likes Pharmacological class effects: all GLP-1 agonists slow gastric emptying and suppress appetite. Those are class effects, not unique to one compound. Effects that differ…
-
Lean mass preservation: what the evidence supports — does this still hold? Replied, post #72 · Outcomes › Body composition · 8 May 2026 · 0 likes Building on post #69 rather than restating it. Agreed on Lean mass preservation, with one qualification that I think matters. The reasoning holds for the case as…
-
[2026 update] Waist circumference technique and its repeatability Replied, post #8 · Outcomes › Progress reports · 7 May 2026 · 5 likes One more thing on Waist circumference technique that took me far too long to see: the two figures people quote are not measuring the same quantity. Once you notice…
-
Blinding yourself: practical methods and their limits Replied, post #23 · Research Methods › N-of-1 designs · 5 May 2026 · 28 likes Seconded. It reads as careful rather than confident, which is the right register.
-
[2026 update] Charge states for a 4 kDa peptide, worked through Replied, post #113 · Analytics › Mass spectrometry · 25 Apr 2026 · 0 likes Positional isomers and epimers are mass-identical. Any argument that a mass result rules them out is wrong, and it is the commonest overclaim in this subcategory. The…
-
Converting between mg/mL and units per dose, both directions — the long version Replied, post #99 · Practice › Reconstitution · 24 Apr 2026 · 0 likes Preservative effectiveness is tested against a defined microbial challenge under defined conditions. It is not a licence to treat an entered vial as sterile…
-
What a certificate commits its issuer to — one year on Replied, post #55 · Analytics › COA interpretation · 24 Apr 2026 · 9 likes Everything in post #53 holds. The case it does not cover is the one I have. An itemised related-substances table with retention times says considerably more about the…
-
Journal club: is percentage weight change the right endpoint? Replied, post #50 · Evidence › Journal club · 8 Apr 2026 · 4 likes The most common failure mode is spending fifty minutes on the effect size and ten on the population. Reversing that ratio would improve most sessions. If it helps: the…
-
[2026 update] Storing lyophilised material long term: what governs the shelf life Replied, post #89 · Practice › Storage & stability · 29 Mar 2026 · 1 like I read post #85 twice before replying, because I had assumed the opposite. What I want from this Storing lyophilised material long term thread is the list of things…
-
Follow-up: Search filters: what is missing Replied, post #50 · Meta › Site feedback · 10 Mar 2026 · 9 likes Post #48 put the caveat in the right place and I want to underline it. Search and findability: if you searched for something and did not find it, report what you…
-
Coming back to: Washout: how long is long enough, and for what purpose Replied, post #58 · Pharmacology › Pharmacokinetics · 2 Mar 2026 · 30 likes I disagree with the framing of Washout above, and I think it is a substantive disagreement rather than a terminological one. Setting out why, so it can be checked. The…
-
Trifluoroacetate content and its consequences Replied, post #14 · Analytics › Impurities & related substances · 23 Jan 2026 · 16 likes Everything in post #10 holds. The case it does not cover is the one I have. Disulfide formation: if a peptide contains cysteine, it can form disulfide bonds with itself…
-
Publication bias detection and its low power — does this still hold? Replied, post #7 · Evidence › Meta-analyses · 16 Jan 2026 · 29 likes Two questions I would want answered before drawing anything from the Publication bias detection data above: how were the cases selected, and what happened to the ones…
-
Coming back to: Training through a dose escalation week Replied, post #9 · Nutrition & Training › Resistance training · 15 Jan 2026 · 1 like Where somebody is losing strength rapidly, the first questions are intake, sleep and total training volume, in that order. Noting that I have skin in this question and…
-
A partial dose because the pen emptied mid-injection Replied, post #56 · Practice › Administration · 9 Jan 2026 · 0 likes Air in the syringe is a much smaller problem subcutaneously than the anxiety about it suggests, and it is still worth expelling because the bubble occupies volume you…
-
Aggregates and why a purity assay may miss them entirely Replied, post #34 · Analytics › Impurities & related substances · 28 Dec 2025 · 2 likes Post #32 put the caveat in the right place and I want to underline it. The strongest argument against my own position on aggregates, stated as well as I can state it,…
-
Promotion criteria, and the one that stops most nominations — the long version Replied, post #118 · Documentation › Doc review · 23 Dec 2025 · 16 likes Coming back to post #117, because the follow-up matters more than the original answer. The version of Promotion criteria that I was taught turned out to be a teaching…
-
Publishing an inconvenient result: a case study — the long version Replied, post #70 · Sourcing › Independent verification · 14 Dec 2025 · 2 likes It does not extend to lots nobody has seen, it is not a recommendation, and it says nothing about anything other than what was measured.
-
The headache that turns out to be dehydration Replied, post #90 · Nutrition & Training › Hydration & electrolytes · 11 Dec 2025 · 0 likes Building on post #87 rather than restating it. Nobody has said the unglamorous part of headache yet, so: most of the variation is explained by things that are boring to…
-
Lipase elevation without symptoms: the interpretation problem Replied, post #16 · Clinical › Bloodwork · 8 Dec 2025 · 23 likes Right — I had this wrong and I am glad to have read it before it mattered.
-
Price changes over 2025 and 2026, tabulated and dated — does this still hold? Replied, post #31 · Access › Pricing · 6 Dec 2025 · 14 likes Fine by me. I had wanted a stronger conclusion and there is not one available.
-
Comparing two chromatograms from different laboratories, properly Replied, post #34 · Analytics › HPLC & UHPLC · 25 Nov 2025 · 2 likes Purity by chromatography answers "what proportion of what I detected is the intended species". It does not answer how much is in the vial, which is a separate assay.
-
Revisiting: Absolute versus relative contraindications Replied, post #6 · Safety › Contraindications · 24 Nov 2025 · 0 likes Interaction-based contraindications are compound-pair specific and are the ones most often generalised incorrectly.
-
Journal club: PIONEER 6 as a safety trial Replied, post #9 · Evidence › Journal club · 23 Nov 2025 · 0 likes A definition problem is doing most of the work in this PIONEER 6 discussion. Once the term is pinned down I suspect the disagreement mostly goes away and what is left…
-
Coming back to: Feature request: should a dose-equivalence tool exist at all? Replied, post #11 · Data & Tools › Calculators · 18 Nov 2025 · 8 likes A tool that refuses to give an answer when the result falls below one graduation is doing something useful. Most just print the number. I have seen it go both ways,…
-
[2026 update] What steady state means for the decision to escalate Replied, post #110 · Practice › Dosing & titration · 16 Nov 2025 · 0 likes This is the first time the answer has come with its own limits attached. Appreciated.
-
Pen dose counters: what a click does and does not guarantee Replied, post #15 · Devices › Pens & autoinjectors · 13 Nov 2025 · 0 likes Post #11 and I disagree about the size of the effect, not about the direction. The instruction leaflet for a licensed pen is a genuinely good technical document and is…
-
Moderation log format change Replied, post #7 · Meta › Announcements · 7 Nov 2025 · 0 likes Practical answer on moderation log format change, since the theoretical one is upthread: do the simplest check first, write down the result, and only then decide…
-
MHRA statements, read directly Replied, post #21 · Regional › UK & Ireland · 26 Oct 2025 · 20 likes I keep a log for MHRA statements specifically because my memory of it turned out to be systematically wrong in one direction. Six weeks of notes cost nothing and…
-
Titles that describe the question, not the situation Replied, post #131 · Start Here › How to Ask · 25 Oct 2025 · 0 likes The most useful reply I ever got about titles was a request to state my units. It sounds like pedantry and it has saved me twice.
-
New subcategory: rationale and scope Replied, post #47 · Meta › Announcements · 17 Oct 2025 · 3 likes I would be cautious about generalising from the new subcategory example above. It is a good example. It is one example.
-
[2026 update] Scheduled maintenance and what will be unavailable Replied, post #16 · Meta › Announcements · 14 Oct 2025 · 11 likes Building on post #14 rather than restating it. An update on my earlier Scheduled maintenance post: the pattern held for another six weeks and then stopped, which I did…
-
Coming back to: The SOUL trial and oral semaglutide cardiovascular outcomes Replied, post #43 · Compounds › Oral incretins · 28 Sep 2025 · 0 likes The most useful thing anyone has posted about SOUL trial and oral semaglutide in this category was a table of what had been measured and by whom. That is what I would…
-
Why the timeline is on the right and not the left Replied, post #62 · Meta › Site feedback · 1 Sep 2025 · 10 likes The strongest argument against my own position on timeline, stated as well as I can state it, since nobody else has yet.
-
Vagal afferents and the gut-brain pathway — one year on Started this topic · Pharmacology › Receptor biology · 28 Aug 2025 · 17 likes Vagal afferents and the gut-brain pathway — one year on Writing it up because I had to work it out twice and would rather nobody else did. An honest uncertainty about…
-
Reaching a dose and staying there for a year: a longitudinal note — does this still hold? Replied, post #32 · Practice › Dosing & titration · 27 Aug 2025 · 12 likes Nothing to add on the substance. Thank you for taking the question at face value.
-
Second pass at: Why this subcategory is stricter about sourcing than most Replied, post #95 · Compounds › Secretagogues & GH axis · 24 Aug 2025 · 26 likes Reconstitution volumes in this family are often small enough that dead volume in the syringe is a meaningful fraction of the dose. A fixed-needle insulin syringe is…
-
Enforcement priorities versus written rules — does this still hold? Replied, post #16 · Sourcing › Regulatory · 18 Aug 2025 · 0 likes Reframing Enforcement priorities slightly, because I think the disagreement is about the question rather than the answer. If the question is "does it happen", yes. If…
-
A request that was declined, and the reasoning — a second dataset Replied, post #29 · Documentation › Wiki requests · 8 Aug 2025 · 0 likes Grateful for the specificity. Vague answers to this question are what sent me looking.
-
Tirzepatide in type 2 diabetes: the SURPASS programme, summarised honestly Replied, post #153 · Compounds › Tirzepatide · 2 Aug 2025 · 7 likes Titration schedules for tirzepatide have more dose steps than semaglutide partly because the compound is more potent and partly because the clinical programme used a…
-
Coming back to: Official shortage notices and what they authorise Replied, post #63 · Access › Shortages · 20 Jul 2025 · 0 likes Post #61 describes the usual case. This is about the unusual one. Compounding during shortages: some jurisdictions allow pharmacy compounding when a marketed product is…
-
Second pass at: A history of disordered eating: proceeding carefully Replied, post #78 · Wellbeing › Mental health · 27 Jun 2025 · 9 likes I have no financial interest in anything named in this thread and I want to say so before I comment on history of disordered eating, because it is the sort of subject…
-
Area percent versus weight percent: the confusion that causes most arguments — what… Replied, post #29 · Analytics › HPLC & UHPLC · 26 Jun 2025 · 6 likes The thing about Area percent versus weight percent that took me longest to accept is that a plausible mechanism is not evidence of an effect. It is a reason to look,…
-
Detection wavelength and why 214 nm and 280 nm disagree Replied, post #10 · Analytics › HPLC & UHPLC · 22 Jun 2025 · 0 likes Post #8 describes the usual case. This is about the unusual one. The confident answers on detection wavelength and the well-sourced answers are not the same answers,…
-
[2026 update] Cardiovascular risk: reading the outcome trials as a set Replied, post #54 · Clinical › Comorbidities · 18 Jun 2025 · 15 likes Post #53 answers the question as asked. The question underneath it is different. Where I have landed on Cardiovascular risk, having got it wrong once in public: the…
-
Semaglutide versus liraglutide head to head: reading STEP 8 carefully Replied, post #12 · Compounds › Semaglutide · 9 Jun 2025 · 0 likes The practical version of semaglutide versus liraglutide is three sentences long. The rigorous version is three pages and reaches the same conclusion with the conditions…
-
A report I filed that turned out to be wrong, and the correction Replied, post #81 · Sourcing › Vendor reports · 1 Jun 2025 · 15 likes Same experience here, different supplier, so it is at least not unique to one of them.
-
Checking someone else's arithmetic: a worked example thread Replied, post #51 · Practice › Reconstitution · 26 May 2025 · 4 likes Preservative effectiveness is tested against a defined microbial challenge under defined conditions. It is not a licence to treat an entered vial as sterile…
-
UK access routes, dated and sourced — a second dataset Replied, post #82 · Regional › UK & Ireland · 24 May 2025 · 17 likes Anyone quoting an eligibility threshold should say which document it comes from. The thresholds have changed and the old ones are still circulating. It is the sort of…
-
Why plausible mechanism is not evidence of effect Replied, post #5 · Compounds › Repair & healing peptides · 13 Apr 2025 · 8 likes Reframing plausible mechanism slightly, because I think the disagreement is about the question rather than the answer. If the question is "does it happen", yes. If it…
-
Review: a draft on reconstitution arithmetic, with objections Replied, post #99 · Documentation › Doc review · 10 Apr 2025 · 0 likes Fact-checking: if you see a factual claim in a maintained page that you have evidence contradicts, post the evidence here. The maintainer will review and correct if you…
-
Coming back to: What published stability data actually covers, and what it does not Replied, post #15 · Practice › Storage & stability · 3 Apr 2025 · 0 likes Nobody has said the unglamorous part of published stability data actually covers yet, so: most of the variation is explained by things that are boring to write about…
-
Request declined, with reasoning Replied, post #2 · Meta › Feature requests · 25 Mar 2025 · 14 likes Deprecation requests: if you think a feature should be removed or changed, that is also a request. Explain why you think it would improve the site. I have kept the…
-
Coverage for the indication versus for the drug Replied, post #2 · Access › Insurance & coverage · 14 Mar 2025 · 4 likes The strongest argument against my own position on coverage, stated as well as I can state it, since nobody else has yet.
-
Triple agonism: additive, synergistic, or neither? Replied, post #25 · Compounds › Retatrutide · 9 Mar 2025 · 1 like On post #23 — agreed on the reasoning, with one qualification. Whether triple agonism is additive or synergistic is an open question and the published work does not…
-
Pharmaceutical compounding rules, summarised from primary sources Replied, post #95 · Sourcing › Regulatory · 3 Mar 2025 · 0 likes If you can confirm or contradict a position for your own region, please date the answer. An undated regional claim is the least useful thing in this category. I checked…
-
Second pass at: Pharmacy supply in the UK and the questions you will be asked Replied, post #20 · Regional › UK & Ireland · 3 Mar 2025 · 23 likes I read post #16 twice before replying, because I had assumed the opposite. Answering the Pharmacy supply question as asked, then the question I think is meant. As…
-
Pharmaceutical compounding rules, summarised from primary sources Replied, post #74 · Sourcing › Regulatory · 2 Mar 2025 · 12 likes Contradicting a claim in this subcategory is most useful when it comes with a link to the primary source and a date of access. Small point, but it is the one that…
-
A ten-fold dose error caught before injection Replied, post #5 · Devices › Syringes & needles · 2 Mar 2025 · 15 likes A detachable luer needle plus hub can retain enough volume to matter. Whether it matters to you depends on your dose, and the arithmetic is worth doing once.
-
Reading an MS report that only gives you a single number — the long version Replied, post #3 · Analytics › Mass spectrometry · 28 Jan 2025 · 0 likes Calibration matters: a high-resolution instrument out of calibration can report mass with ppm error large enough to be uninformative. Check when the instrument was last…
-
Distinguishing a deletion sequence by mass alone Replied, post #15 · Analytics › Mass spectrometry · 24 Jan 2025 · 0 likes Adding the measurement that post #13 says would settle it. Quantitation by MS: most quantitation is done by LC-UV detection at 214 nm, not by MS, because extinction…
-
What we do not know about retatrutide, listed explicitly Replied, post #58 · Compounds › Retatrutide · 16 Jan 2025 · 14 likes I had written a reply contradicting post #54 and deleted it. Here is what survived. Nausea and vomiting were dose-related in the phase 2 work, as they are throughout…
-
Follow-up: Individual participant data versus aggregate data Replied, post #79 · Evidence › Meta-analyses · 11 Jan 2025 · 12 likes Double extraction with disagreement resolution is standard and is worth checking for, because single extraction errors are common and non-random. The disagreement above…
-
[2026 update] New subcategory: rationale and scope Replied, post #112 · Meta › Announcements · 1 Jan 2025 · 0 likes Confirming post #110 from a second method, which matters more than confirming it from a second person. The useful distinction on New subcategory is between what was…
-
What a stability-indicating method is and how you demonstrate one — one year on Replied, post #102 · Analytics › Method validation · 24 Dec 2024 · 5 likes The practical version of stability-indicating method is three sentences long. The rigorous version is three pages and reaches the same conclusion with the conditions…
-
Coming back to: An 18-month record including the parts that went badly Replied, post #2 · marked as the solution · Outcomes › Progress reports · 22 Dec 2024 · 8 likes Worth separating two things that the opening post runs together. 18-month record is worth one more sentence than it usually gets, and the sentence is the one about how…
-
[2026 update] New subcategory: rationale and scope Replied, post #62 · Meta › Announcements · 13 Dec 2024 · 7 likes Reading back through the New subcategory threads from last year, the same three questions come up every time and only one of them has ever been answered properly. That…
-
Semaglutide half-life: where the 165 to 184 hour figure comes from — what changed since Replied, post #58 · Compounds › Semaglutide · 7 Dec 2024 · 0 likes This follows post #57 rather than contradicting it. On alcohol: the labelling does not contraindicate it, but it raises gastric irritation risk and semaglutide already…
-
Injection-site reactions: describing them precisely enough to be useful Replied, post #44 · Practice › Side effects · 3 Dec 2024 · 15 likes Injection-site reactions are usually local, brief and unremarkable. A reaction spreading over a day, or accompanied by systemic symptoms, is a different thing and needs…
-
What a stability-indicating method is and how you demonstrate one — one year on Replied, post #82 · Analytics › Method validation · 27 Nov 2024 · 7 likes Why two laboratories may disagree: after validating the same method, they may still report different purity on the same sample due to integration differences, column…
-
Converting between mg/mL and units per dose, both directions Replied, post #69 · Practice › Reconstitution · 29 Oct 2024 · 0 likes Do not shake. Swirl, or leave it. Vigorous agitation introduces air and shear, and neither helps a peptide go into solution any faster than patience does.
-
Turnaround times and what they mean for a decision — one year on Replied, post #10 · Sourcing › Independent verification · 28 Oct 2024 · 4 likes Interpreting a result: a purity figure is one measurement on one vial on one day. Agreement across two services is much stronger. A single high number does not…
-
Hypertension improvement and when medication needs revisiting — a second dataset Replied, post #100 · Clinical › Comorbidities · 25 Oct 2024 · 33 likes Hypertension improvement has a well-known answer and a correct answer, and the interesting work is establishing that they are the same. Nobody has done that here yet.
-
Requesting a page: what makes a good request — what changed since Replied, post #107 · Documentation › Wiki requests · 12 Oct 2024 · 17 likes Scope the request narrowly. A page about one thing gets written and stays current; a page about a field does not. I have kept the units in throughout, for the obvious…
-
Second pass at: A payment that went through twice: how it was resolved Started this topic · Sourcing › Payments · 16 Sep 2024 · 2 likes On the subject in the title: Second pass at: A payment that went through twice: how it was resolved Working notes rather than a conclusion. A payments question, with…
-
The topic list is dense — is that deliberate? Replied, post #20 · Meta › Site feedback · 31 Aug 2024 · 32 likes The counter-argument is that a review date on a topic implies a maintenance promise nobody has made. A document carries one because somebody signed up to it. On balance…
-
Tracking a preprint to publication: a worked example — the long version Replied, post #25 · Evidence › Preprints · 11 Aug 2024 · 14 likes Where a preprint's numbers are the basis of a claim being repeated here, someone should check whether the published version exists yet. That check is nearly always…
-
Tracking a preprint to publication: a worked example — the long version Replied, post #4 · Evidence › Preprints · 31 May 2024 · 30 likes If you cite a preprint in a maintained document here, the convention is to label it in the sentence and to note the check date. The document review will catch the…